NEGRINI, Massimo
 Distribuzione geografica
Continente #
NA - Nord America 21.892
EU - Europa 6.031
AS - Asia 4.368
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 9
AF - Africa 5
Totale 32.327
Nazione #
US - Stati Uniti d'America 21.835
CN - Cina 2.208
IT - Italia 1.425
UA - Ucraina 1.304
SG - Singapore 963
DE - Germania 961
TR - Turchia 856
GB - Regno Unito 643
PL - Polonia 496
SE - Svezia 417
FI - Finlandia 323
ID - Indonesia 141
FR - Francia 112
BE - Belgio 106
VN - Vietnam 85
CA - Canada 56
CZ - Repubblica Ceca 54
RU - Federazione Russa 49
NL - Olanda 32
RO - Romania 31
IR - Iran 28
HK - Hong Kong 27
IN - India 24
AT - Austria 21
LT - Lituania 21
KR - Corea 11
BR - Brasile 9
IE - Irlanda 9
AU - Australia 8
CH - Svizzera 8
EU - Europa 8
JP - Giappone 7
TW - Taiwan 5
ES - Italia 4
GR - Grecia 4
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BD - Bangladesh 2
BG - Bulgaria 2
CL - Cile 2
GH - Ghana 2
PK - Pakistan 2
PT - Portogallo 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
CO - Colombia 1
CV - Capo Verde 1
DK - Danimarca 1
EE - Estonia 1
HR - Croazia 1
HU - Ungheria 1
IQ - Iraq 1
KZ - Kazakistan 1
MD - Moldavia 1
MK - Macedonia 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
Totale 32.327
Città #
Fairfield 2.943
Woodbridge 2.756
Houston 1.850
Chandler 1.546
Jacksonville 1.501
Ashburn 1.436
Ann Arbor 1.188
Seattle 1.074
Wilmington 1.021
Cambridge 903
Santa Clara 726
Singapore 722
Izmir 561
Warsaw 493
Beijing 471
Nanjing 467
Ferrara 358
Princeton 346
New York 324
San Diego 272
Boardman 243
Shanghai 201
Milan 200
Nanchang 140
Jakarta 139
Shenyang 129
Los Angeles 117
Bremen 110
Dearborn 103
Brussels 99
Tianjin 92
Addison 90
Falls Church 87
Dong Ket 81
Changsha 73
Hebei 71
Jiaxing 68
London 64
Jinan 61
Mountain View 61
San Mateo 55
Kunming 52
Munich 50
Redwood City 48
Brno 45
Washington 45
Norwalk 44
Bologna 42
Ningbo 39
Zhengzhou 38
Helsinki 37
Guangzhou 36
Rome 35
Auburn Hills 34
Toronto 34
Tappahannock 29
Verona 29
Philadelphia 28
Augusta 27
Hangzhou 26
Orange 26
Des Moines 25
Hong Kong 22
Leawood 22
Frankfurt am Main 21
Hefei 21
Vienna 19
Indiana 18
Ottawa 17
Taizhou 17
Timisoara 17
Lanzhou 16
Napoli 16
Ardabil 15
Changchun 15
Monmouth Junction 13
Redmond 13
Kilburn 12
Naples 12
Amsterdam 11
Bari 10
Chicago 10
Monte San Pietro 10
Dublin 8
Ferrara di Monte Baldo 8
Haikou 8
Palermo 8
San Jose 8
Acton 7
San Giorgio Di Piano 7
Trieste 7
Hounslow 6
Pavia 6
Prescot 6
San Francisco 6
Wuhan 6
Cleveland 5
Istanbul 5
Lappeenranta 5
Messina 5
Totale 24.449
Nome #
Applicazione della tecnica di metilazione specifica PCR (MSP) con un pannel di quattro markers su campioni citologici di patologia mammaria. 539
MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches 294
BK virus-plasmid expression vector that persists episomally in human cells and shuttles into Escherichia coli 232
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 189
Absolute quantification of cell-free microRNAs in cancer patients 188
MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab 185
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 177
Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers 172
Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR 171
High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy 168
Mesenchymal Progenitors Aging Highlights a miR-196 Switch Targeting HOXB7 as Master Regulator of Proliferation and Osteogenesis 167
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 164
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 162
N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration 154
Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus 153
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model 153
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 152
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 152
13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinicopathologic features 149
MicroRNA e cancro 149
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 149
p53/MDM2 Feed-back Loop Sustains miR-221 Expression and Dictates the Response to Anticancer Treatments in Hepatocellular Carcinoma 145
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 144
Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: Correlation with clinicobiologic features 138
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 138
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer 137
Multiple loci on human chromosome 11 control tumorigenicity of BK virus transformed cells 136
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 136
MicroRNA involvement in hepatocellular carcinoma 135
A novel t(9;11)(p22;q23) with ALL-1 gene rearrangement associated with progression of a myeloproliferative disorder to acute myeloid leukemia 135
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells 135
Circulating non-coding RNA as biomarkers in colorectal cancer 135
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 135
Downregulation of the mitochondrial calcium uniporter by cancer-related miR-25 134
Refined subchromosomal location of 21 expressed sequence tags from unknown genes at region 11p15 133
null 132
MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation 132
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 132
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 132
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 132
Alterations of the tumor suppressor gene ARLTS1 in ovarian cancer 131
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 131
Transcriptional map of 170-kb region at chromosome 11p15.5: Identification and mutational analysis of the BWR1A gene reveals the presence of mutations in tumor samples 131
Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma 130
Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study 130
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 129
Circulating microRNAs, MIR-939, MIR-595, MIR-519d and MIR-494, identify cirrhotic patients with HCC 129
RASSF1A QUANTITATIVE METHYLATION-SPECIFIC DROPLET DIGITAL PCR IN URINARY CELLS AS BIOMARKER FOR PROSTATE CANCER DETECTION 129
null 128
An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues 127
Anticancer activity of an adenoviral vector expressing short hairpin RNA against BK virus T-ag 126
Combining anti-miR-155 with chemotherapy for the treatment of lung cancers 126
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 126
MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis 126
In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2 125
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 125
Tumor suppressor functions of ARLTS1 in lung cancers 125
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 125
Detection of DNA mutations in urine of patients with prostate cancer by NGS technology 125
A transcriptome-wide approach reveals the key contribution of NFI-A in promoting erythroid differentiation of human CD34(+) progenitors and CML cells 124
miRNA array screening reveals cooperative MGMT-regulation between miR-181d-5p and miR-409-3p in glioblastoma 124
microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters 122
Reprogramming of miRNA networks in cancer and leukemia 120
Cryptic insertion producing two NUP98/NSD1 chimeric transcripts in adult refractory anemia with an excess of blasts 120
Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers 120
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis 119
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 119
Cloning and characterization of a senescence inducing and class II tumor suppressor gene in ovarian carcinoma at chromosome region 6q27 118
A BK virus episomal vector for constitutive high expression of exogenous cDNAs in human cells 118
REFINED KARYOTYPE-BASED PROGNOSTIC STRATIFICATION OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH A VERY LOW RISK GENETIC PROFILE 118
MicroRNA response to environmental mutagens in liver 118
Extensive modulation of a set of microRNAs in primary glioblastoma 117
Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival 117
MicroRNA deregulation in human thyroid papillary carcinomas 116
mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer 115
MiR-145 participates with TP53 in a death promoting regulatory loop and targets estrogen receptor in human breast cancer cells 115
Clinical Monoclonal B lymphocytosis versus Rai 0 Chronic Lymphocytic Leukemia: a Comparison of Cellular, Cytogenetic, Molecular, and Clinical Features 115
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia 115
Significance of Aberrant Expression of MicroRNAs in Cancer Cells 114
Evidence for BK virus as a human tumor virus 114
NUP98 is fused to the NSD3 gene in acute myeloid leukemia associated with t(8;11)(p11.2;p15) 114
Gain of imprinting at chromosome 11p15: a pathogenetic mechanism identified in human hepatocarcinomas 114
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 114
Expression of herpes simplex virus 1 glycoprotein B in human cells and protection of mice against lethal herpes simplex virus 1 infection 114
TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia 114
Animal Models of Hepatocellular Carcinoma Prevention 114
Regulatory mechanisms of microRNAs involvement in cancer 114
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 113
Cloning and characterization of two overlapping genes in a subregion at 6q21 involved in replicative senescence and schizophrenia 112
miR-126&126* Restored Expressions Play a Tumor Suppressor Role by Directly Regulating ADAM9 and MMP7 in Melanoma 112
Cooperation in oncogenesis between BK virus early region gene and the activated human c-Harvey RAS oncogene 112
Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia 112
Minor myeloid component in Ph chromosome-positive acute lymphoblastic leukaemia: correlation with cytogenetic pattern and implication for poor response to therapy 111
null 111
Evidence for BK virus as a human tumor virus. 111
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance 111
Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients 111
A microRNA signature of hypoxia 111
Simian virus 40 infection in humans and association with human diseases: results and hypotheses 110
Non-coding RNAs change their expression profile after Retinoid induced differentiation of the promyelocytic cell line NB4 110
Totale 13.742
Categoria #
all - tutte 150.336
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.164
Totale 156.500


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.354 0 0 0 0 492 813 632 676 571 697 293 180
2020/20214.955 399 436 345 503 209 470 202 510 126 692 701 362
2021/20223.752 139 356 300 169 193 188 217 219 122 271 360 1.218
2022/20233.610 390 233 128 466 604 522 162 301 454 32 189 129
2023/20242.169 187 245 95 58 169 498 112 186 44 42 59 474
2024/20252.322 188 179 650 350 955 0 0 0 0 0 0 0
Totale 32.831